Sanofi Consumer Healthcare India Ltd. Q1 results PAT up 12.9%

Sanofi Consumer Healthcare India Ltd. announced it's Q1 results with PAT at ₹500 million, which stands 12.9% above last quarter of Q4 2024. With an increase of ₹2.4 per share, landing the EPS at ₹21.7. The Company reported revenue from operations of ₹1726 million.

Commenting on the results, Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, "We continue to focus on strengthening our operations and continues to bring superior, simple and accessible products that enable consumers to control their own health. Our commitment to delivering high-quality, science-backed products remains at the core of our integrated growth strategy."

The Q1 2025 also witnessed a successful launch of Allegra D, an addition to the existing portfolio of Allegra variants in India; a brand with over 25 years legacy in India.

Q1 2025 and Q1 2024 are not directly comparable, due to demerger and voluntary product recall of certain variants of key brands.

Shares of Sanofi Consumer Healthcare India Limited was last trading in BSE at Rs. 4938.45 as compared to the previous close of Rs. 4942.35. The total number of shares traded during the day was 1204 in over 94 trades.

The stock hit an intraday high of Rs. 4949.95 and intraday low of 4901.05. The net turnover during the day was Rs. 5947116.00.

Source : Equity Bulls

Keywords

SanofiConsumerHealthcareIndia INE0UOS01011 Pharmaceuticals Q1 ResultUpdate